Abstract |
Necroptosis is a regulated caspase-independent cell death pathway with morphological features resembling passive non-regulated necrosis. Several diverse structure classes of necroptosis inhibitors have been reported to date, including a series of 3,3a,4,5-tetrahydro-2H-benz[g] indazoles (referred to as the Nec-3 series) displaying potent activity in cellular assays. However, evaluation of the tricyclic necroptosis inhibitor's stability in mouse liver microsomes indicated that they were rapidly degraded. A structure-activity relationship (SAR) study of this compound series revealed that increased liver microsomal stability could be accomplished by modification of the pendent phenyl ring and by introduction of a hydrophilic substituent (i.e., α- hydroxyl) to the acetamide at the 2-position of the tricyclic ring without significantly compromising necroptosis inhibitory activity. Further increases in microsomal stability could be achieved by utilizing the 5,5-dioxo-3-phenyl-2,3,3a,4-tetrahydro-[1]benzothiopyrano[4,3-c] pyrazoles. However, in this case necroptosis inhibitory activity was not maintained. Overall, these results provide a strategy for generating potent and metabolically stable tricyclic necrostatin analogs (e.g., 33, LDN-193191) potentially suitable for in vivo studies.
|
Authors | Sungwoon Choi, Heather Keys, Richard J Staples, Junying Yuan, Alexei Degterev, Gregory D Cuny |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 22
Issue 17
Pg. 5685-8
(Sep 01 2012)
ISSN: 1464-3405 [Electronic] England |
PMID | 22832318
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 Elsevier Ltd. All rights reserved. |
Chemical References |
|
Topics |
- Animals
- Drug Stability
- Humans
- Indazoles
(chemistry, metabolism, pharmacology)
- Jurkat Cells
- Mice
- Microsomes, Liver
(metabolism)
- Models, Molecular
- Necrosis
(drug therapy)
- Pyrazoles
(chemistry, metabolism, pharmacology)
- Structure-Activity Relationship
|